Global Neuroprotection Market Research Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Neuroprotection Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Neuroprotection Market Overview:
Global Neuroprotection Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Neuroprotection involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Neuroprotection Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Neuroprotection market in 2020.
Global Neuroprotection Market Segmentation
By Type, Neuroprotection market has been segmented into:
Free Radical Trapping Agents (Antioxidants)
Glutamate Antagonists (Anti-Excitotoxic Agents)
Apoptosis Inhibitors
Anti-inflammatory Agents
Neurotrophic Factors (NTFs)
Metal Ion Chelators
Stimulants
Others
By Application, Neuroprotection market has been segmented into:
Prevention
Treatment
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Neuroprotection market are:
Daiichi Sankyo Company
Eli Lilly and Company
Allergan
Dr. Reddy’s Laboratories
Teva Pharmaceutical
Novartis
AstraZeneca
Astrocyte Pharmaceuticals
F. Hoffmann-La Roche
Biogen
1. Market Overview of Neuroprotection
1.1 Neuroprotection Market Overview
1.1.1 Neuroprotection Product Scope
1.1.2 Market Status and Outlook
1.2 Neuroprotection Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Neuroprotection Historic Market Size by Regions (2015-2020)
1.4 Neuroprotection Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Neuroprotection Sales Market by Type (2015-2026)
2.1 Global Neuroprotection Historic Market Size by Type (2015-2020)
2.2 Global Neuroprotection Forecasted Market Size by Type (2021-2026)
2.3 Free Radical Trapping Agents (Antioxidants)
2.4 Glutamate Antagonists (Anti-Excitotoxic Agents)
2.5 Apoptosis Inhibitors
2.6 Anti-inflammatory Agents
2.7 Neurotrophic Factors (NTFs)
2.8 Metal Ion Chelators
2.9 Stimulants
2.10 Others
3. Covid-19 Impact Neuroprotection Sales Market by Application (2015-2026)
3.1 Global Neuroprotection Historic Market Size by Application (2015-2020)
3.2 Global Neuroprotection Forecasted Market Size by Application (2021-2026)
3.3 Prevention
3.4 Treatment
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Neuroprotection Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Neuroprotection Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Neuroprotection Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Neuroprotection Business
5.1 Daiichi Sankyo Company
5.1.1 Daiichi Sankyo Company Company Profile
5.1.2 Daiichi Sankyo Company Neuroprotection Product Specification
5.1.3 Daiichi Sankyo Company Neuroprotection Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Eli Lilly and Company
5.2.1 Eli Lilly and Company Company Profile
5.2.2 Eli Lilly and Company Neuroprotection Product Specification
5.2.3 Eli Lilly and Company Neuroprotection Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Allergan
5.3.1 Allergan Company Profile
5.3.2 Allergan Neuroprotection Product Specification
5.3.3 Allergan Neuroprotection Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Dr. Reddy’s Laboratories
5.4.1 Dr. Reddy’s Laboratories Company Profile
5.4.2 Dr. Reddy’s Laboratories Neuroprotection Product Specification
5.4.3 Dr. Reddy’s Laboratories Neuroprotection Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Teva Pharmaceutical
5.5.1 Teva Pharmaceutical Company Profile
5.5.2 Teva Pharmaceutical Neuroprotection Product Specification
5.5.3 Teva Pharmaceutical Neuroprotection Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Novartis
5.6.1 Novartis Company Profile
5.6.2 Novartis Neuroprotection Product Specification
5.6.3 Novartis Neuroprotection Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 AstraZeneca
5.7.1 AstraZeneca Company Profile
5.7.2 AstraZeneca Neuroprotection Product Specification
5.7.3 AstraZeneca Neuroprotection Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Astrocyte Pharmaceuticals
5.8.1 Astrocyte Pharmaceuticals Company Profile
5.8.2 Astrocyte Pharmaceuticals Neuroprotection Product Specification
5.8.3 Astrocyte Pharmaceuticals Neuroprotection Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 F. Hoffmann-La Roche
5.9.1 F. Hoffmann-La Roche Company Profile
5.9.2 F. Hoffmann-La Roche Neuroprotection Product Specification
5.9.3 F. Hoffmann-La Roche Neuroprotection Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Biogen
5.10.1 Biogen Company Profile
5.10.2 Biogen Neuroprotection Product Specification
5.10.3 Biogen Neuroprotection Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Neuroprotection Market Size (2015-2026)
6.2 North America Neuroprotection Key Players in North America (2015-2020)
6.3 North America Neuroprotection Market Size by Type (2015-2020)
6.4 North America Neuroprotection Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Neuroprotection Market Size (2015-2026)
7.2 East Asia Neuroprotection Key Players in North America (2015-2020)
7.3 East Asia Neuroprotection Market Size by Type (2015-2020)
7.4 East Asia Neuroprotection Market Size by Application (2015-2020)
8. Europe
8.1 Europe Neuroprotection Market Size (2015-2026)
8.2 Europe Neuroprotection Key Players in North America (2015-2020)
8.3 Europe Neuroprotection Market Size by Type (2015-2020)
8.4 Europe Neuroprotection Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Neuroprotection Market Size (2015-2026)
9.2 South Asia Neuroprotection Key Players in North America (2015-2020)
9.3 South Asia Neuroprotection Market Size by Type (2015-2020)
9.4 South Asia Neuroprotection Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Neuroprotection Market Size (2015-2026)
10.2 Southeast Asia Neuroprotection Key Players in North America (2015-2020)
10.3 Southeast Asia Neuroprotection Market Size by Type (2015-2020)
10.4 Southeast Asia Neuroprotection Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Neuroprotection Market Size (2015-2026)
11.2 Middle East Neuroprotection Key Players in North America (2015-2020)
11.3 Middle East Neuroprotection Market Size by Type (2015-2020)
11.4 Middle East Neuroprotection Market Size by Application (2015-2020)
12. Africa
12.1 Africa Neuroprotection Market Size (2015-2026)
12.2 Africa Neuroprotection Key Players in North America (2015-2020)
12.3 Africa Neuroprotection Market Size by Type (2015-2020)
12.4 Africa Neuroprotection Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Neuroprotection Market Size (2015-2026)
13.2 Oceania Neuroprotection Key Players in North America (2015-2020)
13.3 Oceania Neuroprotection Market Size by Type (2015-2020)
13.4 Oceania Neuroprotection Market Size by Application (2015-2020)
14. South America
14.1 South America Neuroprotection Market Size (2015-2026)
14.2 South America Neuroprotection Key Players in North America (2015-2020)
14.3 South America Neuroprotection Market Size by Type (2015-2020)
14.4 South America Neuroprotection Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Neuroprotection Market Size (2015-2026)
15.2 Rest of the World Neuroprotection Key Players in North America (2015-2020)
15.3 Rest of the World Neuroprotection Market Size by Type (2015-2020)
15.4 Rest of the World Neuroprotection Market Size by Application (2015-2020)
16 Neuroprotection Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Neuroprotection Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|